OBJECTIVE: To investigate qualitatively and quantitatively the performance of a programme for managing the child contacts of adult tuberculosis patients in Indonesia. METHODS: A public health evaluation framework was used to assess gaps in a child contact management programme at a lung clinic. Targets for programme performance indicators were derived from established programme indicator targets, the scientific literature and expert opinion. Compliance with tuberculosis screening, the initiation of isoniazid preventive therapy in children younger than 5 years, the accuracy of tuberculosis diagnosis and adherence to preventive therapy were assessed in 755 child contacts in two cohorts. In addition, 22 primary caregivers and 34 clinic staff were interviewed to evaluate knowledge and acceptance of child contact management. The cost to caregivers was recorded. Gaps between observed and target indicator values were quantified. FINDINGS: THE GAPS BETWEEN OBSERVED AND TARGET PERFORMANCE INDICATORS WERE: 82% for screening compliance; 64 to 100% for diagnostic accuracy, 50% for the initiation of preventive therapy, 54% for adherence to therapy and 50% for costs. Many staff did not have adequate knowledge of, or an appropriate attitude towards, child contact management, especially regarding isoniazid preventive therapy. Caregivers had good knowledge of screening but not of preventive therapy and had difficulty travelling to the clinic and paying costs. CONCLUSION: The study identified widespread gaps in the performance of a child contact management system in Indonesia, all of which appear amenable to intervention. The public health evaluation framework used could be applied in other settings where child contact management is failing.
OBJECTIVE: To investigate qualitatively and quantitatively the performance of a programme for managing the child contacts of adult tuberculosispatients in Indonesia. METHODS: A public health evaluation framework was used to assess gaps in a child contact management programme at a lung clinic. Targets for programme performance indicators were derived from established programme indicator targets, the scientific literature and expert opinion. Compliance with tuberculosis screening, the initiation of isoniazid preventive therapy in children younger than 5 years, the accuracy of tuberculosis diagnosis and adherence to preventive therapy were assessed in 755 child contacts in two cohorts. In addition, 22 primary caregivers and 34 clinic staff were interviewed to evaluate knowledge and acceptance of child contact management. The cost to caregivers was recorded. Gaps between observed and target indicator values were quantified. FINDINGS: THE GAPS BETWEEN OBSERVED AND TARGET PERFORMANCE INDICATORS WERE: 82% for screening compliance; 64 to 100% for diagnostic accuracy, 50% for the initiation of preventive therapy, 54% for adherence to therapy and 50% for costs. Many staff did not have adequate knowledge of, or an appropriate attitude towards, child contact management, especially regarding isoniazid preventive therapy. Caregivers had good knowledge of screening but not of preventive therapy and had difficulty travelling to the clinic and paying costs. CONCLUSION: The study identified widespread gaps in the performance of a child contact management system in Indonesia, all of which appear amenable to intervention. The public health evaluation framework used could be applied in other settings where child contact management is failing.
Authors: Sobenna A George; Catherine A Ko; H Lester Kirchner; Jeffrey R Starke; Therese A Dragga; Anna M Mandalakas Journal: Pediatr Infect Dis J Date: 2011-05 Impact factor: 2.129
Authors: Yodi Mahendradhata; Riris A Ahmad; Theodorus A Kusuma; Marleen Boelaert; Marieke J Van der Werf; Michael E Kimerling; Patrick Van der Stuyft Journal: Trans R Soc Trop Med Hyg Date: 2008-06-20 Impact factor: 2.184
Authors: Almério Machado; B Finkmoore; K Emodi; I Takenami; T Barbosa; M Tavares; M G Reis; S Arruda; L W Riley Journal: Int J Tuberc Lung Dis Date: 2009-06 Impact factor: 2.373
Authors: Susan S van Wyk; Anthony J Reid; Anna M Mandalakas; Donald A Enarson; Nulda Beyers; Julie Morrison; Anneke C Hesseling Journal: BMC Public Health Date: 2011-07-08 Impact factor: 3.295
Authors: Leonardo Martinez; Ye Shen; Andreas Handel; Srijita Chakraburty; Catherine M Stein; LaShaunda L Malone; W Henry Boom; Frederick D Quinn; Moses L Joloba; Christopher C Whalen; Sarah Zalwango Journal: Lancet Respir Med Date: 2017-12-19 Impact factor: 30.700
Authors: S Zawedde-Muyanja; A Nakanwagi; J P Dongo; M P Sekadde; R Nyinoburyo; G Ssentongo; A K Detjen; F Mugabe; J Nakawesi; Y Karamagi; P Amuge; A Kekitiinwa; S M Graham Journal: Int J Tuberc Lung Dis Date: 2018-11-01 Impact factor: 2.373
Authors: U Egere; A Sillah; T Togun; S Kandeh; F Cole; A Jallow; A Able-Thomas; M Hoelscher; N Heinrich; P C Hill; B Kampmann Journal: Public Health Action Date: 2016-12-21
Authors: Yesaya K Mwasubila; Issa Sabi; Rogatus Kabyemera; Nyanda E Ntinginya; Reginald Sauve; Benson Kidenya Journal: East Afr Health Res J Date: 2018-04-01
Authors: Andreas Sandgren; Marije Vonk Noordegraaf-Schouten; Femke van Kessel; Anke Stuurman; Anouk Oordt-Speets; Marieke J van der Werf Journal: BMC Infect Dis Date: 2016-05-17 Impact factor: 3.090
Authors: Daria Szkwarko; Yael Hirsch-Moverman; Lienki Du Plessis; Karen Du Preez; Catherine Carr; Anna M Mandalakas Journal: PLoS One Date: 2017-08-01 Impact factor: 3.240